DST Global is an investment firm or fund tracked for its market and portfolio activity.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
DST Global (Yuri Milner) invested in Biorce's $52.5M Series A after intensive due diligence including 3-day founder shadowing and a demo to ex-GSK/Genentech/Rush executives. They bypassed standard reference calls, convinced by Biorce's hypergrowth (0 to $10M ARR in 9 months) and unique clinical trial automation thesis.